Patient from (b)(6), had called up regarding the hip replacement compensation, in reference to the news he read in the newspaper.He said that he had undergone a surgery of hip replacement in the year 2005 at (b)(6) by dr.The patient was very hyper as he is facing side effect by the surgery.Thus, wants an urgent call back from the concern person for the same within an hour.He also informed that he had already spoken to the food and drugs department regarding the same.Doi: (b)(6) 2005; right hip.
|
Depuy synthes is submitting this report pursuant to the provision of 21 cfr, part 803.The report may be based on the information which depuy synthes has not been able to investigate or verify prior to the required reporting date.This report does not reflect a conclusion by fda, depuy synthes or its employees that the report constitutes an admission that the device, depuy synthes, or its employees caused or contributed to the potential event described in this report.H10 additional narrative: product complaint # (b)(4).Investigation summary: the asr platform was voluntarily recalled from the market in (b)(6) 2010, and the asr product codes are now considered inactive.Further investigation of this individual incident will not be undertaken.The investigation regarding the root cause(s) and/or corrective actions was conducted under mdd capa(b)(4).Ongoing post market surveillance is conducted per our procedures for this product.Device history lot: null.Device history batch: null.Device history review: null.If information is obtained that was not available for the initial medwatch, a follow-up medwatch will be filed as appropriate.
|